Furthermore, it has been shown that there is a discordance in the PD-L1 expression between primary malignant breast tumors and metastatic breast tumors; this scenario highlights the importance of appropriate tissue sampling from metastatic biopsies and the urgent need for standardization of laboratory protocols for PD-L1 evaluation [313]. This evidence concerns the gene CD274 and breast cancer.